China National Biotech Group
The Latest
-
Sinopharm Group's COVID-19 Inactivated Vaccine Approved For Clinical Trials
The state-owned pharmaceutical company's second inactivated vaccine received clinical trial approval from regulators after showing promising results. The state-owned pharmaceutical company's second inactivated vaccine received clinical trial approval from regulators after showing promising results.